Literature DB >> 31104967

MMSE Changes During and After ECT in Late-Life Depression: A Prospective Study.

Jasmien Obbels1, Kristof Vansteelandt2, Esmée Verwijk3, Annemieke Dols4, Filip Bouckaert5, Mardien L Oudega4, Mathieu Vandenbulcke6, Max Stek4, Pascal Sienaert2.   

Abstract

OBJECTIVE: There is ongoing concern about the impact of electroconvulsive therapy (ECT) on cognition in patients with late-life depression (LLD), especially in patients for whom pretreatment Mini-Mental State Exam (MMSE) scores are low. Our aim was to examine the evolution of cognitive effects of ECT, using the MMSE in a large group of patients with LLD.
METHODS: One hundred nine patients aged 55 years and older with unipolar depression, referred for ECT, were included in our study. The MMSE was assessed before, during, immediately after, and 6 months after ECT.
RESULTS: MMSE scores improved significantly during the course of ECT and remained stable during the 6-month period after ending ECT for the total group. In the group of patients with a low MMSE score (<24) at baseline, the MMSE score improved significantly during ECT, whereas in the group of patients with a normal MMSE score (≥24) at baseline, the score did not change significantly during ECT. In both groups, MMSE scores still increased slightly after ECT was discontinued.
CONCLUSION: ECT does not cause deleterious cognitive effects, as measured with the MMSE, during and for 6 months after the ECT course in patients with LLD. In the event of a baseline cognitive impairment, MMSE scores tend to improve significantly during and for 6 months after the ECT course. The presence of pretreatment cognitive impairment should not lead clinicians to withhold ECT in older patients with severe depression.
Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECT; cognition; late-life depression

Year:  2019        PMID: 31104967     DOI: 10.1016/j.jagp.2019.04.006

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

1.  The Effects of Baseline Impaired Global Cognitive Function on the Efficacy and Cognitive Effects of Electroconvulsive Therapy in Geriatric Patients: A Retrospective Cohort Study.

Authors:  James Luccarelli; Brent P Forester; Mary Dooley; Regan E Patrick; David G Harper; Stephen J Seiner; Georgios Petrides; Martina Mueller; Michael E Henry
Journal:  Am J Geriatr Psychiatry       Date:  2021-12-17       Impact factor: 7.996

2.  Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-A randomized, double-blind, controlled clinical study.

Authors:  Lei Zou; Su Min; Qibin Chen; Xiao Li; Li Ren
Journal:  Brain Behav       Date:  2020-12-11       Impact factor: 2.708

3.  Plant-based dietary patterns and cognitive function: A prospective cohort analysis of elderly individuals in China (2008-2018).

Authors:  Anna Zhu; Changzheng Yuan; Jules Pretty; John S Ji
Journal:  Brain Behav       Date:  2022-07-14       Impact factor: 3.405

4.  Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.

Authors:  Sarah H Lisanby; Shawn M McClintock; William V McCall; Rebecca G Knapp; C Munro Cullum; Martina Mueller; Zhi-De Deng; Abeba A Teklehaimanot; Matthew V Rudorfer; Elisabeth Bernhardt; George Alexopoulos; Samuel H Bailine; Mimi C Briggs; Emma T Geduldig; Robert M Greenberg; Mustafa M Husain; Styliani Kaliora; Vassilios Latoussakis; Lauren S Liebman; Georgios Petrides; Joan Prudic; Peter B Rosenquist; Shirlene Sampson; Kristen G Tobias; Richard D Weiner; Robert C Young; Charles H Kellner
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-17       Impact factor: 4.105

5.  Prophylactic cognitive enhancers for improvement of cognitive function in patients undergoing electroconvulsive therapy: A systematic review and meta-analysis.

Authors:  Yunlian Niu; Dan Ye; Yijie You; Jian Wu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.